Hybrid Closed-Loop in Diabetes Post-Kidney Transplant: A Randomized Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hybrid Closed-Loop in Diabetes Post-Kidney Transplant: A Randomized Trial — Stella

Home/Diabetes Mellitus Patients With Kidney Transplantation/

View on ClinicalTrials.gov

Recruiting

Back to Diabetes Mellitus Patients With Kidney Transplantation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Shanxi Bethune Hospital, Taiyuan, Shanxi

Key details

Sponsor

Shanxi Bethune Hospital

Enrollment target

~30 participants

Started

April 2025

Primary completion

August 2026

Age range

18 Years – 70 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.